Assays for hepatitis B surface antigen (HBsAg) are the most frequently ... Beyond 14 days, there were no reactive or grayzone HBsAg tests that could be attributed to recent HBV vaccination.

Precision BioSciences (NASDAQ:DTIL) stock gains as company reports promising Phase 1 trial results for its Hepatitis B gene ...

Precision BioSciences reports early PBGENE-HBV trial data showing safety and antiviral activity in chronic Hepatitis B patients, with more results expected in 2025.

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...

The trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.

The Microsoft Surface Laptop 7th Edition (15-inch) is a powerful, well-engineered machine with a bright display and a lengthy lifespan. Its design is a little plain but it excels in every other ...

bepirovirsen at a dose of 300 mg per week over 24 weeks resulted in sustained hepatitis B surface antigen (HBsAg) and HBV DNA loss to below the limits of detection in 9% to 10% of participants ...

Non-Blocking Reactive Streams Foundation for the JVM both implementing a Reactive Extensions inspired API and efficient event streaming support. Since 3.3.x, this repository also contains ...

There is a strong suggestion that HCC is a disease which will be seen more frequently over the next few years, mainly as a result of the hepatitis C virus (HCV) epidemic. Previously, HCC has been a ...